This inventor holds 22 USPTO granted patents, plus 1 CIPO patent. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Astellas Pharma Gmbh. Active years: 1986-2008.
Location History:
- Midorigaoka, JP (1987)
- Ikeda, JP (1986 - 1988)
- Kawabe, JP (1992 - 1993)
- Hyogo, JP (1990 - 2002)
- Osaka, JP (2006 - 2008)
Company Filing History:
19 out of 940 
3 out of 424 
Years Active: 1986-2008
Title: Atsushi Akahane: Innovator in Pyrazine Derivatives
Introduction: Atsushi Akahane, based in Hyogo, Japan, is a prolific inventor with an impressive portfolio of 22 patents. His work focuses on the development of pharmaceutical compounds, particularly in the field of neuroscience and mental health.
Latest Patents: Among Akahane's most notable recent inventions is a series of patents that cover pyrazine derivatives and their pharmaceutical applications. These compounds function as adenosine antagonists and have potential uses in preventing and treating various conditions such as depression, dementia (including Alzheimer's disease and Parkinson's-related dementia), anxiety, pain, cerebrovascular diseases like stroke, and heart failure.
Career Highlights: Atsushi Akahane has contributed significantly to the pharmaceutical industry through his roles at well-known companies like Fujisawa Pharmaceutical Company Ltd. and Astellas Pharma GmbH. His innovative work has advanced therapeutic options in psychiatry and neurology.
Collaborations: Throughout his career, Akahane has collaborated with esteemed professionals, including Youichi Shiokawa and Hirohito Katayama. These partnerships highlight his commitment to advancing medical science and contributing to meaningful health solutions.
Conclusion: Atsushi Akahane exemplifies a dedicated innovator in the pharmaceutical field, with a strong focus on pyrazine derivatives that hold promise for addressing critical health issues. His contributions continue to influence both scientific research and clinical applications, ensuring a lasting impact on the industry.